Please login to the form below

Not currently logged in
Email:
Password:

GSK's Ellen Strahlman joins med tech firm BD

Will serve as the US company's chief medical officer

BD Dr Ellen StrahlmanNew Jersey-based medical technology company BD (Becton, Dickinson and Company) has appointed Dr Ellen Strahlman to the newly created role of chief medical officer and senior VP, research and development.

Dr Strahlman joins the firm from GlaxoSmithKline (GSK), which she joined in 2008, serving first as chief medical officer, and then senior medical advisor in the office of the CEO and global head of neglected tropical diseases.

Prior to her time with GSK, Dr Strahlman held executive leadership roles at Merck & Co, Novartis, Pfizer and Bausch & Lomb.

In her new role at BD Dr Strahlman will oversee the company's medical affairs and research and development functions.

"I am very pleased that Dr Strahlman will be joining BD at a time when we are strategically focused on driving growth through innovation and customer focus," said BD's CEO Vincent Forlenza. "She brings extensive experience as a senior physician and leader in the pharmaceutical and medical device industries, and her patient-centric approach aligns with our focus on providing innovative solutions to address the healthcare needs of customers and patients."

Headquartered in Franklin Lakes, New Jersey, BD develops, manufactures and sells medical devices, instrument systems and reagents.

14th March 2013

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Founded in 201, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...